Sun Pharmaceutical Industries Ltd Share Price
(SUNPHARMA)
₹1734.7▲0.19%
as on 04:01PM, 28 Mar 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 9.44 % |
3 Month Return | -8.04 % |
1 Year Return | + 6.47 % |
Market Stats | |
Previous Close | ₹1,731.45 |
Open | ₹1,731.45 |
Volume | 19.57L |
Upper Circuit | ₹1,904.55 |
Lower Circuit | ₹1,558.30 |
Market Cap | ₹4,16,212.64Cr |
P/E Ratio
36.37
PEG Ratio
3.43
Market Cap
₹4,16,212.64 Cr
P/B Ratio
16.41
EPS
40.21
Dividend Yield
0.83
Sector
Pharmaceuticals
ROE
12.05
based on 37 analysts
81.08%
Buy
10.81%
Hold
8.11%
Sell
Based on 37 analysts offering long term price targets for Sun Pharma. An average target of ₹2051.84
Source: S&P Global Market Intelligence
Sun Pharma price forecast by 37 analysts
Upside of18.28%
High
₹2450
Target
₹2051.84
Low
₹1475
Sun Pharma target price ₹2051.84, a slight upside of 18.28% compared to current price of ₹1734.7. According to 37 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Sun Pharma revenue growth forecast
Expected growth rate Q1, FY2027:32.10%
Forecast
Actual
Including amortisation and stock based compensations
Sun Pharma EPS growth forecast
EPS estimate Q1, FY2027:56.33%
Forecast
Actual
Source: S&P Global Market Intelligence
Sun Pharma Enters Merger Agreement with Checkpoint Therapeutics - 29 Mar, 2025
Sun Pharma Faces Challenges Amid Market Decline - 27 Mar, 2025
Sun Pharma Shares Surge with Increased Trading Volume - 21 Mar, 2025
Sun Pharma Plans Experimental Drug for Obesity - 20 Mar, 2025
Sun Pharma Acquires Antibe Therapeutics for Growth - 19 Mar, 2025
Sun Pharma Gains on Acquisition and Profit Growth - 18 Mar, 2025
Sun Pharma Issues Recall for Morphine Sulfate Tablets - 16 Mar, 2025
Sun Pharma Exhibits Signs of Recovery and Momentum - 15 Mar, 2025
Sun Pharma Shows Positive Momentum with Strong Indicators - 14 Mar, 2025
Sun Pharma's Strategic Acquisition Boosts Specialty Portfolio - 13 Mar, 2025
Sun Pharma Acquires Checkpoint Therapeutics for $355 Million - 10 Mar, 2025
HSBC Lowers Target Price for Sun Pharma Shares - 06 Mar, 2025
Sun Pharma to Launch New Obesity Drug Soon - 03 Mar, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 4 quarters, 12.58K Cr → 14.14K Cr (in ₹), with an average increase of 3.8% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 18.02% to 18.05% in Dec 2024 quarter
Retail Holding Up
Retail Investor have increased holdings from 8.89% to 8.92% in Dec 2024 quarter
Price Rise
In the last 1 month, SUNPHARMA stock has moved up by 9.4%
MF Holding Up
Mutual Funds have increased holdings from 12.11% to 12.24% in Dec 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 61.9% return, outperforming this stock by 55.4%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 54.48% of holdings in Dec 2024 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 129.8% return, outperforming this stock by 41.1%
Profit Down
Netprofit is down for the last 2 quarters, 3.04K Cr → 2.90K Cr (in ₹), with an average decrease of 4.5% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 54.48% | 0.00 | |
Foreign Institutions | 18.05% | 0.17 | |
Mutual Funds | 12.24% | 1.02 | |
Retail Investors | 8.92% | 0.33 | |
Others | 6.31% |
Sun Pharma in the last 5 years
Lowest (19.47x)
March 23, 2020
Today (36.37x)
March 28, 2025
Industry (53.18x)
March 28, 2025
Highest (184.63x)
August 28, 2020
Sun Pharmaceutical Industries Ltd’s net profit jumped 15.04% since last year same period to ₹2,903.38Cr in the Q3 2024-2025. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated -4.5% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending December 2024, Sun Pharmaceutical Industries Ltd has declared dividend of ₹10.50 - translating a dividend yield of 1.38%.
Read More about DividendsBearish
Neutral
Bullish
Sun Pharmaceutical Industries Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹4,16,212.64 Cr | 78.48% | 0.68 | ₹9,648 Cr | ₹48,496 Cr | |
HOLD | ₹1,53,320.05 Cr | 38.07% | 0.50 | ₹1,600 Cr | ₹7,845 Cr | |
BUY | ₹1,09,243.59 Cr | 45.48% | 0.67 | ₹1,656 Cr | ₹10,727 Cr | |
BUY | ₹41,024.50 Cr | 5.26% | 0.58 | ₹1,297 Cr | ₹14,755 Cr | |
HOLD | ₹26,235.81 Cr | -2.5% | 0.50 | ₹772 Cr | ₹5,664 Cr |
Organisation | Sun Pharma |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Sun Pharmaceutical Industries Ltd share price today stands at ₹1734.7, Open: ₹1731.45, Previous Close: ₹1731.45, High: ₹1741.35, Low: ₹1705.2, 52 Week High: ₹1960.35, 52 Week Low: ₹1377.2.
Today's traded volume of Sun Pharmaceutical Industries Ltd(SUNPHARMA) is 19.57L.
Today's market capitalisation of Sun Pharmaceutical Industries Ltd(SUNPHARMA) is ₹416212.64Cr.
Sun Pharmaceutical Industries Ltd (SUNPHARMA) share price is ₹1734.7. It is down -11.51% from its 52 Week High price of ₹1960.35
Sun Pharmaceutical Industries Ltd (SUNPHARMA) share price is ₹1734.7. It is up 25.96% from its 52 Week Low price of ₹1377.2